People with HIV who have developed resistance to 3TC (lamivudine) can still achieve viral load suppression using boosted protease inhibitor regimens that include 3TC as part of the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) "backbone", researchers reported this week at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.
B.C. researcher Robert Hogg knew that a frequently used cocktail of drugs was helping people with HIV live longer than expected. He was also well aware of studies, regional in focus, that showed drugs taken in combination were keeping AIDS at bay.
A team of UK researchers, led by Robert Hogg of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, suggested in their research Thursday that cocktails of HIV drugs help patients live an average of 13 years longer.
Hundreds of people with HIV are dying without ever taking the drug cocktails that could prolong their lives for decades -- and those most at risk are the poor, the homeless, the mentally ill and the drug-addicted.
Pharmacy data can be used as a simple low-cost tool for monitoring a patient's adherence to HIV therapy in resource-limited areas, according to a study by researchers from the Johns Hopkins Bloomberg School of Public Health and other organizations.